Sun Pharma gets US FDA approval for Topiramate; stk up
March 30th, 2009
Sun Pharmaceutical Industries had touched an intraday high of Rs 1,102 and an intraday low of Rs 1,080.50. At 10:01 am, the share was quoting at Rs 1,101.95, up Rs 21.45, or 1.99% on the NSE.
The company has got US FDA approval for generic anti-seizure drug Topiramate, reports CNBC-TV18.
It was trading with volumes of 15,637 shares. On Friday the share closed up 0.62% or Rs 6.65 at Rs 1,080.50.